Neueste Versuche

EudraCT Number: 2017-004851-22

Sponsor Protocol Number: B7451015

Start Date:

Sponsor Name: Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001, U.S.A.

Full Title: A phase 3 multi-center, long-term extension study investigating the efficacy and safety of Abrocitinib, with or without topical medications, administered to subjects aged 12 years and older with m...

Medical condition: Moderate to severe atopic dermatitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	100000004858	10003639	Atopic dermatitis	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) CZ (Ongoing) HU (Trial now transitioned) PL (Ongoing) NL (Ongoing) BG (Ongoing) BE (Ongoing) LV (Ongoing) ES (Ongoing) SK (Completed) FR (Completed) AT (Completed) SE (Prematurely Ended) IT (Ongoing) FI (Ongoing) RO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-004828-11

Sponsor Protocol Number: RECHMPL18_0038_prom_7574

Start Date:

Sponsor Name: University Hospital of Montpellier

Full Title: Phosphodiesterase-type 5 inhibitors in adult and adolescent patients with univentricular heart disease: a multi-center, randomized, double blind phase III study

Medical condition: adult and adolescent patients with univentricular heart diseases and pulmonary arterial pressure

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2017-003220-78

Sponsor Protocol Number: I8B-MC-ITSA

Start Date:

Sponsor Name: Eli Lilly and Company

Full Title: A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults with Type 1 Diabetes Mellitus

Medical condition: Diabetes Mellitus, Type 1

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10012601	Diabetes mellitus	PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2014-002442-45

Sponsor Protocol Number: AXAFA-AFNET5

Start Date:

Sponsor Name: Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)]

Full Title: Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy.

Medical condition: Atrial fibrillation catheter ablation

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.0	10007541 - Cardiac disorders	10003658	Atrial fibrillation	PT
	19.0	10007541 - Cardiac disorders	10071667	Persistent atrial fibrillation	LLT
	19.0	10007541 - Cardiac disorders	10003661	Atrial fibrillation paroxysmal	LLT
	19.0	10007541 - Cardiac disorders	10066582	Recurrent atrial fibrillation	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) BE (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) AT (Completed)

Trial results: (No results available)

EudraCT Number: 2006-006907-35

Sponsor Protocol Number: SP915

Start Date:

Sponsor Name: Schwarz Biosciences GmbH

Full Title: Long-term extension of RECOVER A MULTICENTER, MULTINATIONAL, PHASE 3B, OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE LONG-TERM EFFECT OF THE 24-HOUR TRANSDERMAL DELIVERY OF ROTIGOTINE ON MOTOR FUNCTI...

Medical condition: Parkinson's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10061536	Parkinson's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) FI (Completed) ES (Completed) HU (Completed) IT (Completed) GB (Completed) AT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2005-005641-19

Sponsor Protocol Number: ENG K001 GF / EC 406

Start Date:

Sponsor Name: Takeda Pharma GmbH

Full Title: 3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients with Ut...

Medical condition: Uterine fibroids (Uterus myomatosus)

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.0		10046784		LLT

Population Age: Adults

Gender: Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2019-003676-39

Sponsor Protocol Number: 109147

Start Date:

Sponsor Name:

Full Title: Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS)

Medical condition: In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barri...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-006912-31

Sponsor Protocol Number: AMV-12_12_2006

Start Date:

Sponsor Name: Universitätsklinikum Schleswig-Holstein

Full Title: Vereidung maschineller Beatmung bei sehr kleinen Frühgeborenen - Avoid mechanical ventilation (The AMV-Trial)

Medical condition: Respiratory distress syndrom of preterm infants (ICD 10: P22.0)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Under 18

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-000412-30

Sponsor Protocol Number: LF111/401

Start Date:

Sponsor Name: Chemo Research S.L.

Full Title: A multicenter, open-label, controlled study to investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral density (BMD) in adolescent and adult women in comparison with...

Medical condition: Oral contraception

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10022891 - Investigations	10049470	Bone density decreased	PT

Population Age: Adolescents, Under 18, Adults

Gender: Female

Trial protocol: CZ (Ongoing) PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-000205-77

Sponsor Protocol Number: KF5503-75

Start Date:

Sponsor Name: Grünenthal GmbH

Full Title: Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged...

Medical condition: Moderate to severe acute pain

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	100000004867	10066714	Acute pain	LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: PL (Completed)

Trial results: View results

Neueste Versuche

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen